Spots Global Cancer Trial Database for A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.

Official Title: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Trunk, Extremities and Face.

Study ID: NCT02667236

Conditions

Seborrheic Keratosis

Interventions

A-101 Solution

Vehicle Solution

Study Description

Brief Summary: This is a randomized, double-blind, vehicle-controlled, parallel group study of A-101 Solution 40% compared with Vehicle Solution.

Detailed Description: This is a randomized, double-blind, vehicle-controlled, parallel group study. During this study, the investigator will identify 4 eligible SK Target Lesions on each subject on the trunk, extremities and face. The Target Lesions will be treated, by an investigational staff member other than the evaluating investigator, a maximum of two times.